在药品临床试验中对欺诈和不当行为进行刑事处罚
Nataliya Gutorova1, Vitalii Pashkov2, Oleksii Soloviov3
1YAROSLAV MUDRYI NATIONAL LAW UNIVERSITY, KHARKIV, UKRAINE.
概括
在药品临床试验中将欺诈定为刑事犯罪,应集中在严重违规行为上. 处罚应针对威胁受试者的安全,权利或伪造疗效和安全数据的行为,遵守最后比例原则.
科学领域:
- 法律医学是法律医学.
- 制药法 制药法 制药法
- 临床试验法规 临床试验法规
背景情况:
- 定义药品临床试验中不当行为的刑事责任范围是复杂的.
- 现有的法律框架可能无法充分解决欺诈和不当行为的细微差别.
- 需要在这个领域对犯罪的原则性方法.
研究的目的:
- 建立一个科学基础的框架,以将临床试验中的欺诈和不当行为定为刑事犯罪.
- 确定这种刑事犯罪的适当基础和限制.
- 促进对这些关键的法律和道德问题的认识和讨论.
主要方法:
- 欧盟,乌克兰,德国和波兰法律的比较法律分析.
- 审查来自美国,法国和乌克兰的司法实践.
- 利用了来自乌克兰的法律统计和立法草案.
- 采用科学研究方法,包括诱导,推断,比较,分析,案例研究和系统分析.
主要成果:
- 该研究确定了多个司法管辖区的关键法律和司法先例.
- 分析揭示了在临床试验中规范不当行为的不同方法.
- 法律统计和立法草案提供了关于乌克兰当前监管趋势的见解.
结论:
- 对于临床试验中非法行为的刑事处罚应该保留给最严重的违规行为.
- 应用终极比例原则至关重要,重点关注对生命/健康的威胁,侵犯权利或伪造疗效/安全数据.
- 并非所有违法行为都需要刑事处罚;基于原则的方法是必不可少的.
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Clinically Relevant Drug Product Specifications: Methods of Establishment
195
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
195


